Global Retirement Partners LLC Invests $433,000 in HCA Healthcare, Inc. $HCA

Global Retirement Partners LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,131 shares of the company’s stock, valued at approximately $433,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter valued at about $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare in the 1st quarter worth approximately $26,000. WPG Advisers LLC purchased a new position in HCA Healthcare during the first quarter valued at approximately $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Finally, Chung Wu Investment Group LLC bought a new position in HCA Healthcare in the 2nd quarter worth $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Robert W. Baird upped their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. KeyCorp raised their target price on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Oppenheimer increased their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Finally, JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $474.53.

HCA Healthcare Trading Down 0.4%

HCA opened at $512.94 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00. The stock has a 50-day moving average of $452.07 and a 200 day moving average of $406.38. The firm has a market cap of $117.05 billion, a P/E ratio of 19.83, a P/E/G ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.